FLT3 INHIBITORS FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Santos, A. [1 ]
Pereira, C. [1 ]
Freitas, D. [2 ]
机构：
[1] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[2] Univ Jose do Rosario Vellano UNIFENAS BH, Belo Horizonte, MG, Brazil
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
MT1
引用
收藏
页码：S378 / S378
页数：1
相关论文
共 50 条
  • [41] FLT3 Inhibitors for Treating Acute Myeloid Leukemia
    Hassanein, Mona
    Almahayni, Muhamad H.
    Ahmed, Syed O.
    Gaballa, Sameh
    El Fakih, Riad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (10): : 543 - 549
  • [42] FLT3 Inhibitors in Acute Myeloid Leukemia: An Update
    Stone, R. M.
    ANNALS OF HEMATOLOGY, 2011, 90 : S70 - S72
  • [43] The Development of FLT3 Inhibitors in Acute Myeloid Leukemia
    Garcia, Jacqueline S.
    Stone, Richard M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (04) : 663 - +
  • [44] FLT3 Inhibitors in the Management of Acute Myeloid Leukemia
    Zappone, E.
    Defina, M.
    Aprile, L.
    Bartalucci, G.
    Gozzetti, A.
    Bocchia, M.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (08) : 1028 - 1032
  • [45] Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia
    Song, Moo-Kon
    Park, Byeong-Bae
    Uhm, Ji-Eun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [46] Efficacy of FLT3 Inhibitors in Acute Myeloid Leukemia (AML): A Network Meta-Analysis of Randomized Controlled Trials
    Jha, Tathagata
    Goel, Archit
    Gupta, Ishan
    Govekar, Siddhant
    Saravanan, Praveen Bharath
    Sharma, Sakshi
    Suresh, Vinay
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S316 - S317
  • [47] The role of FLT3 inhibitors in the treatment of FLT3-mutated acute myeloid leukemia
    Fathi, Amir T.
    Chen, Yi-Bin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (04) : 330 - 336
  • [48] Real-World Use of FLT3 Tyrosine Kinase Inhibitors in Patients with Relapsed/Refractory FLT3 mutation-Positive Acute Myeloid Leukemia in the United States
    Grinblatt, David L.
    Han, Wei
    Nimke, David
    Feng, Qi
    Sullivan, Loretta
    Pandya, Bhavik J.
    BLOOD, 2021, 138
  • [49] A SYSTEMATIC REVIEW OF THE HUMANISTIC BURDEN OF FLT3-MUTATED RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
    Casamayor, M.
    Gubbels, L.
    Garnham, A.
    Shah, M., V
    VALUE IN HEALTH, 2020, 23 : S29 - S29
  • [50] Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients
    Boluda, Blanca
    Martinez-Cuadron, David
    Algarra, Lorenzo
    Cano, Isabel
    Sayas, Maria J.
    Acuna-Cruz, Evelyn
    Blanco, Albert
    Marco-Ayala, Javier
    DeLapuerta, Rosalia
    Diaz-Gonzalez, Alvaro
    Tormo, Mar
    Rodriguez-Veiga, Rebeca
    Garcia, Raimundo
    Pinana, Jose L.
    Lopez-Pavia, Maria
    Barragan, Eva
    Amigo, Maria L.
    Sargas, Claudia
    Lopez, Aurelio
    Solana-Altabella, Antonio
    Gil, Cristina
    Eduardo Megias-Vericat, Juan
    Sanz, Miguel A.
    Montesinos, Pau
    LEUKEMIA & LYMPHOMA, 2021, 62 (11) : 2727 - 2736
12345